Tag: reMind

Mindbloom publishes the results of largest ketamine study to date

Privately owned psychedelic therapy company Mindbloom announced the positive findings of the largest peer-reviewed study regarding ketamine therapy and psychedelic medicine. The study, published in the Journal of Affective Disorders, was authored by psychiatrists and researchers from Johns Hopkins University School of Medicine, NYU School of Medicine, the Institute for Psycholinguistics and Digital …

Atai bids to buy IntelGenx

IntelGenx Corp. (OTCQB: IGXT) (TSX: IGX) was granted protection under the Companies Creditors Arrangement Act, which is the Canadian version of bankruptcy. The company told investors that on May 27, the court granted an order that approved a sale and investment solicitation process for its assets. The court also approved …

The Daily Hit: June 11, 2024

The Daily Hit is a recap of the top financial news stories for Tuesday, June 11, 2024. On the Site Connecticut governor halts social equity funds, orders review of cannabis council The review comes amid concerns over the council’s transparency and governance practices. Read more here. New York cannabis regulators …